• RegMed XB welcomes new General Director, Bernard Mulder
PUBLISHED
06 Feb 2020
SHARE THIS

RegMed XB welcomes new General Director, Bernard Mulder

RegMed XB welcomes new General Director, Bernard Mulder

The Supervisory Board of RegMed XB is excited to announce the appointment of Bernard Mulder as General Director, effective March 1, 2020.

Bernard joins RegMed XB from Boehringer Ingelheim, where he led the Medical Affairs Department after more than two decades in medical, marketing, sales and management positions in the life sciences. He worked for Organon in Asia, Europe and the USA, ultimately as senior director of the Global Venture Team, and was Global VP Marketing, Sales and Business Development for Avantium Pharma.

In 2011, Bernard co-founded Eagle Rock Life Sciences to support life sciences enterprises from early start-ups to mature companies (hands-on). He earned his medical degree at Leiden University and an MBA from New York Institute of Technology.

We consider ourselves fortunate to have such an experienced innovator, coach and communicator willing to join and lead our team.

Bernard Mulder

Bernard will take over as General Director from Prof. Dr. Marianne van der Steen per 1 March 2020. We thank Marianne for her contribution to founding and setting up RegMed XB and are happy to announce that she will continue to serve on the Executive Board as New Business Development Director together with Frank Luyten (Medical Scientific Director) and Tom Oostrom (Patient Advocate).

Both Bernard and Marianne will engage with stakeholders in their new roles during RegMed XB’s Annual Meeting on 4-5 March in Utrecht. We look forward to the new momentum these appointments will bring to our quest to bring new regenerative medicine solutions to patients.

Have something to share?

Now you can contribute to keep our news section fresh and up-to date with relevant events and grants, research results and high impact publications related to REGMED XB’ Moonshots. Contributions can be sent to This email address is being protected from spambots. You need JavaScript enabled to view it.. Please submit the text in English and include a short title. We are looking forward to your input!

  • Diabetes FondsDiabetes Fonds
  • Leids Universitair Medisch CentrumLeids Universitair Medisch Centrum
  • Provincie UtrechtProvincie Utrecht
  • RijksoverheidRijksoverheid
  • Health HollandHealth Holland
  • Maastricht UMC+Maastricht UMC+
  • Provincie LimburgProvincie Limburg
  • TU/eTU/e
  • NierstichtingNierstichting
  • Provincie Noord-BrabantProvincie Noord-Brabant
  • Universiteit LeidenUniversiteit Leiden
  • LeidenLeiden
  • Stichting DONStichting DON
  • ReumaNederlandReumaNederland
  • Maastricht UniversityMaastricht University
  • UMC UtrechtUMC Utrecht
  • Utrecht UniversityUtrecht University
  • KU LeuvenKU Leuven
  • VIBVIB
  • HartstichtingHartstichting
  • 300Microns300Microns
  • Access2boneAccess2bone
  • Chemelot InSciTeChemelot InSciTe
  • Cyto smartCyto smart
  • Dutch CardioVascular AllianceDutch CardioVascular Alliance
  • Flanders State of the ArtFlanders State of the Art
  • FUJIFILMFUJIFILM
  • GalápagosGalápagos
  • HCM MedicalHCM Medical
  • Kuros BiosciencesKuros Biosciences
  • LifeTec GroupLifeTec Group
  • MateriomicsMateriomics
  • MimetasMimetas
  • Ministerie van Economische Zaken en KlimaatMinisterie van Economische Zaken en Klimaat
  • Ministerie van Onderwijs Cultuur en WetenschapMinisterie van Onderwijs Cultuur en Wetenschap
  • Ministerie van Volksgezondheid, Welzijn en SportMinisterie van Volksgezondheid, Welzijn en Sport
  • NcardiaNcardia
  • Nestegg BiotechNestegg Biotech
  • NTrans TechnologiesNTrans Technologies
  • Ostheo PharmaOstheo Pharma
  • Provincie Zuid-HollandProvincie Zuid-Holland
  • ScinusScinus
  • Starfish InnovationsStarfish Innovations
  • StentitStentit
  • SupraPolixSupraPolix
  • veldlaserveldlaser
  • VisualsonicsVisualsonics
  • XeltisXeltis

Information for

Contact information

  • Stichting REGMED XB
  • Minderbroedersberg 4-6, 6211 LK  Maastricht
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Connect with us

Copyright © 2021 RegMed XB. All rights reserved
Realisation & design by Joomlapartner